Shanghai - Delayed Quote CNY

Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS)

14.79
+0.28
+(1.93%)
At close: May 23 at 3:00:03 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Dr. Zhao Ding Chairman of the Board & GM -- -- 1985
Ms. Lina Ma Director, Deputy GM & Secretary -- -- 1976
Mr. Gang Cai Manager of Technical Department, Quality Manager & Quality Director -- -- 1977

Sichuan Huiyu Pharmaceutical Co., Ltd.

Building 3
No. 333 Hanyang Road Shizhong District
Neijiang, 641000
China
86 83 2880 8001 https://www.huiyupharma.com
Sector: 
Healthcare
Full Time Employees: 
1,382

Description

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor and injection drugs in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, sodium valproate concentrated solution, epirubicin hydrochloride, fulvestrant, milrinone, fluorouracil, sodium thiosulfate, zoledronic acid, zoledronic acid concentrated solution, cisatracurium besylate, bortezomib, octreotide acetate, doxorubicin, and palonosetron hydrochloride. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorportaed in 2010 and is headquartered in Neijiang, China.

Corporate Governance

Sichuan Huiyu Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 24, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

605507.SS Guobang Pharma Ltd.
19.86
+0.71%
 
002099.SZ Zhejiang Hisoar Pharmaceutical Co., Ltd.
6.40
+9.97%
 
603520.SS Zhejiang Starry Pharmaceutical Co.,Ltd.
10.06
+1.93%
 
HROW Harrow, Inc.
25.90
+0.62%